DYRK1A in Down Syndrome: An Oncogene or Tumor Suppressor?

Journal of Clinical Investigation - United States
doi 10.1172/jci62372
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

American Society for Clinical Investigation

Related search

AMPK: A Contextual Oncogene or Tumor Suppressor?

Cancer Research
Cancer ResearchOncology
2013English

SIRT3: Oncogene and Tumor Suppressor in Cancer

Cancers
Cancer ResearchOncology
2017English

A Double-Edged Function of DDX3, as an Oncogene or Tumor Suppressor, in Cancer Progression (Review)

Oncology Reports
MedicineCancer ResearchOncology
2018English

TRAP1 Regulation of Cancer Metabolism: Dual Role as Oncogene or Tumor Suppressor

Genes
Genetics
2018English

P53 Downregulates Down Syndrome-Associated DYRK1A Through miR-1246

EMBO Reports
BiochemistryGeneticsMolecular Biology
2011English

GPRC5A: A Potential Tumor Suppressor and Oncogene

Cancer Biology and Therapy
Cancer ResearchOncologyMolecular MedicinePharmacology
2009English

Attenuation of Notch Signalling by the Down-Syndrome-Associated Kinase DYRK1A

Journal of Cell Science
Cell Biology
2009English

When Tumor Suppressor TGFβ Meets the HER2 (ERBB2) Oncogene

Journal of Mammary Gland Biology and Neoplasia
Cancer ResearchOncology
2011English

Cerebellar Alterations in a Model of Down Syndrome: The Role of the Dyrk1A Gene

Neurobiology of Disease
Neurology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy